J. Pagonabarraga

Motor fluctuations in Parkinson's disease leave a distinct immune fingerprint in blood.
20260 citationsauthor #7
An eight-year follow-up of the CMSAR: assessing how the new MDS criteria and biomarkers impact diagnostic accuracy
20260 citationsauthor #14
Effects of immersive virtual reality and adaptive cognitive training on cognition and function in parkinson’s disease mild cognitive impairment: a randomized clinical trial
20260 citationsauthor #8
Hereditary Ataxias: From Pathogenesis and Clinical Features to Neuroimaging, Fluid, and Digital Biomarkers—A Scoping Review
20260 citationsauthor #4
A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASC
20250 citationsauthor #15
Expanding the clinical–radiological phenotype of SCA34 and its role in the differential diagnosis of the hot cross bun sign
20251 citationsauthor #11
Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline
20255 citationsauthor #144
Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline
20255 citationsauthor #5
Update on Genetic Chorea
20252 citationsauthor #5
Dysphagia in Parkinson´s disease. A 5-year follow-up study
20252 citationsauthor #139
Disrupted visual-to-semantic dynamics promote visual hallucinations in Parkinson’s disease
20250 citationsauthor #8
Early Language Impairment as an Integral Part of the Cognitive Phenotype in Huntington's Disease
20251 citationsauthor #12
A randomized clinical trial to evaluate the efficacy of cognitive rehabilitation and music therapy in mild cognitive impairment in Huntington’s disease
20255 citationsauthor #9
Correction: Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline
20250 citationsauthor #5
Update on the Symptomatic Treatment of Huntington’s Disease: From Pathophysiology to Clinical Practice
20255 citationsauthor #5
Approaches for treating neuropsychiatric symptoms in Parkinson’s disease: a narrative review
20253 citationsauthor #3
Structured clinical diagnostic assessment reveals autism spectrum disorder in adults with functional neurological disorder
20250 citationsauthor #3
CSF Biomarker‐Based Cognitive Trajectories in Parkinson's Disease‐Subjective Cognitive Decline
20250 citationsauthor #4
Fatigue and neuropsychiatric symptoms in Parkinson’s disease: a narrative review
20250 citationsauthor #3
Consolidation deficits in episodic memory define distinct clinical and neurodegenerative profiles in Huntington’s disease
20250 citationsauthor #13
Sleep-like slow waves during wakefulness uncover a malignant form of Parkinson's disease
20250 citationsauthor #8
Connectome-based brain fingerprints predict early cognitive decline in Parkinson’s patients with minor hallucinations
20253 citationsauthor #5
Correction: Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline
20250 citationsauthor #144
Neural and biomarker correlates of the Parkinson's Disease–Cognitive Rating Scale in Huntington's disease
20250 citationsauthor #11
Sex Differences in Parkinson’s Disease: A Narrative Review
202430 citationsauthor #2
Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4‐Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers
202415 citationsauthor #11
Impact of Stimulation Frequency on Verbal Fluency Following Bilateral Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease.
20242 citationsauthor #7
Skin Tau Quantification as a Novel Biomarker in Huntington's Disease
20245 citationsauthor #13
Functional Neurological Disorder and Autism Spectrum Disorder: A Complex and Potentially Significant Relationship
202414 citationsauthor #5
F072 Prevalence, characteristics and correlates of violent and criminal behavior in Huntington disease
20240 citationsauthor #6
Facial emotion recognition deficits are associated with hypomimia and related brain correlates in Parkinson’s disease
20249 citationsauthor #9
Therapeutic Approach to Primary Tic Disorders and Associated Psychiatric Comorbidities
20244 citationsauthor #5
D011 Skin Tau quantification as a novel biomarker in Huntington's disease
20240 citationsauthor #13
Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies
202418 citationsauthor #14
D018 Multimodal analysis of mutant Huntingtin, NfL, and MRI correlations in Huntington's disease
20240 citationsauthor #9
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease
20249 citationsauthor #51
Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years
202438 citationsauthor #82
The discriminative linguistic profiles of progressive supranuclear palsy and Parkinson's disease.
20240 citationsauthor #9
D010 Evaluating amyloid-beta peptides as CSF biomarkers of cognitive status in Huntington's disease
20240 citationsauthor #11
Parkinson disease psychosis: from phenomenology to neurobiological mechanisms
202444 citationsauthor #1
Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease
20247 citationsauthor #9
A Novel Susceptibility Locus in NFASC Highlights Oligodendrocytes and Myelination in Progressive Supranuclear Palsy Pathology
20241 citationsauthor #15
Parkinson's Disease‐Cognitive Rating Scale (PD‐CRS): Normative Data and Mild Cognitive Impairment Assessment in Brazil
20236 citationsauthor #9
Structural and metabolic brain correlates of arithmetic word‐problem solving in Huntington's disease
20233 citationsauthor #5
Baseline Large‐Scale Network Dynamics Associated with Disease Progression in Huntington's Disease
20231 citationsauthor #9
Understanding visual hallucinations: a new synthesis.
202363 citationsauthor #15
Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments
20235 citationsauthor #27
Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders
202328 citationsauthor #1
Cognitive impairment and dementia in young onset Parkinson’s disease
202311 citationsauthor #145
A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease.
20238 citationsauthor #11
Predicting Disability in Progressive Supranuclear Palsy Using Bedside Frontal‐Lobe Signs
20234 citationsauthor #6
Divergent cognitive trajectories in early stage Huntington's disease: A 3‐year longitudinal study
202310 citationsauthor #7
Late‐Onset Beta‐Propeller Protein‐Associated Neurodegeneration: A Case Report
20233 citationsauthor #8
Functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines: a national multicentre observational study
202313 citationsauthor #7
Theta oscillations and minor hallucinations in Parkinson’s disease reveal decrease in frontal lobe functions and later cognitive decline
202211 citationsauthor #2
Genotype–Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and Specificities
20225 citationsauthor #5
Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease.
202226 citationsauthor #1
A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease
202217 citationsauthor #10
Risk of Parkinson's disease in a gout Mediterranean population: A case-control study.
202210 citationsauthor #3
Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson’s Disease
20226 citationsauthor #4
Smoking is associated with age at disease onset in Parkinson's disease.
20225 citationsauthor #58
Cortical macro and microstructural correlates of cognitive and neuropsychiatric symptoms in Parkinson's disease.
20227 citationsauthor #4
Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data
202219 citationsauthor #13
Predicting Impulse Control Disorders in Parkinson Disease through Incentive Biomarkers
20228 citationsauthor #3
Efficacy and safety of high doses of safinamide in advanced Parkinson disease.
20223 citationsauthor #6
Autism Spectrum Disorder May Be Highly Prevalent in People with Functional Neurological Disorders
202217 citationsauthor #3
The role of attentional control over interference in minor hallucinations in Parkinson's disease.
20224 citationsauthor #3
Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration
202232 citationsauthor #10
Plasma TDP-43 Reflects Cortical Neurodegeneration and Correlates with Neuropsychiatric Symptoms in Huntington’s Disease
20226 citationsauthor #11
Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data
20220 citationsauthor #13
Measuring the functional impact of cognitive impairment in Huntington’s disease
20227 citationsauthor #6
Non‐Persistence of Tremorolytic Effect of Perampanel in Essential Tremor: Real‐World Experience with 50 Patients
20223 citationsauthor #5
Predictors of clinically significant quality of life impairment in Parkinson’s disease
20210 citationsauthor #116
Arithmetic Word-Problem Solving as Cognitive Marker of Progression in Pre-Manifest and Manifest Huntington’s Disease
20212 citationsauthor #27
Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
20217 citationsauthor #1
Present and Future of Parkinson’s Disease in Spain: PARKINSON-2030 Delphi Project
202111 citationsauthor #12
Identification of sixteen novel candidate genes for late onset Parkinson’s disease
202171 citationsauthor #136
Robot-induced hallucinations in Parkinson’s disease depend on altered sensorimotor processing in fronto-temporal network
202138 citationsauthor #5
Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease
202156 citationsauthor #175
Neuroanatomical and cognitive correlates of visual hallucinations in Parkinson's disease and dementia with Lewy bodies: Voxel-based morphometry and neuropsychological meta-analysis.
202134 citationsauthor #12
The role of glutamatergic neurotransmission in the motor and non-motor symptoms in Parkinson's disease: Clinical cases and a review of the literature.
202153 citationsauthor #1
Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease
202142 citationsauthor #51
Progression of Motor and Non-Motor Symptoms in Multiple System Atrophy: A Prospective Study from the Catalan-MSA Registry
202118 citationsauthor #8
Present and Future of Parkinson’s Disease in Spain: PARKINSON-2030 Delphi Project
20210 citationsauthor #12
The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide?
202114 citationsauthor #7
Tipping the scales: how clinical assessment shapes the neural correlates of Parkinson’s disease mild cognitive impairment
20218 citationsauthor #16
Cortical microstructural correlates of plasma neurofilament light chain in Huntington's disease.
202117 citationsauthor #8
Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes
202127 citationsauthor #2
Cognitive and Affective Empathy in Huntington’s Disease
20218 citationsauthor #8
Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage
202112 citationsauthor #128
Structure and Dynamics of Large‐Scale Cognitive Networks in Huntington's Disease
202114 citationsauthor #10
Correction to: Utility of the Parkinson’s disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington’s disease
20210 citationsauthor #26
Non‐motor symptom burden is strongly correlated to motor complications in patients with Parkinson’s disease
202049 citationsauthor #94
The impact of freezing of gait on functional dependency in Parkinson’s disease with regard to motor phenotype
202019 citationsauthor #120
A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice
202010 citationsauthor #1
Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders
20200 citationsauthor #23
Neural signatures of predictive language processing in parkinson’s disease with and without mild cognitive impairment
20208 citationsauthor #2
The Free and Cued Selective Reminding Test in Parkinson's Disease Mild Cognitive Impairment: Discriminative Accuracy and Neural Correlates
20207 citationsauthor #2
Depression is Associated with Impulse-compulsive Behaviors in Parkinson's disease.
202012 citationsauthor #8
Structural brain correlates of dementia in Huntington’s disease
202030 citationsauthor #5

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT